Rhaeos is a pioneering company focused on enhancing care for patients with hydrocephalus through its innovative wearable shunt monitor, which utilizes a thermal biosensor. Originating from research at Northwestern University, Rhaeos is the result of a collaborative effort involving experts from engineering, medicine, and management. The company specializes in developing noninvasive wireless patches that monitor the flow of bodily fluids, including blood, lymph, and cerebrospinal fluid. This technology enables timely treatment for chronic medical conditions, particularly in the field of neurosurgery, by providing real-time data on fluid dynamics. Through its advancements, Rhaeos addresses a significant clinical need, improving patient outcomes and care efficiency.
Grove Biopharma is a biotechnology company dedicated to addressing unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. It specializes in the discovery and development of a new class of protein-like polymers, utilizing artificial intelligence and precision polymer chemistry to create hybrid synthetic protein mimetics. The company also provides materials science solutions to tackle challenges associated with peptide therapeutics, thereby facilitating researchers' access to innovative drugs in critical areas of healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.